PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)
Primary Target and PDB code of Protein-Drug complex
NERVOUS SYSTEM CNS STIMULANT AMPHETAMINES SYMPATHOMIMETICS BLOCK THE REUPTAKE OF NOREPINEPHRINE AND DOPAMINE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) AND NARCOLEPSY MONOAMINE TRANSPORTER BLOCKER
PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)
Primary Target and PDB code of Protein-Drug complex
PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)
Primary Target and PDB code of Protein-Drug complex
NERVOUS SYSTEM SYMPATHOMIMETIC AMINE PSYCHOSTIMULANTS TREATMENT OF ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY TREATMENT OF EXOGENOUS OBESITY LEADS TO THE FORMATION OF REACTIVE OXYGEN SPECIES IN THE BRAIN
ORAL
F 67.2 PERCENT (PMID8104133)
VD 242 LITER (65 KILOGRAM)
PPB 15 PERCENT
Cl 17.1 LITER / HOUR (65 KILOGRAM)
HT 12.2 HOUR
DOPAMINE TRANSPORTER (DAT) SEROTONINE TRANSPORTER
PDB4XP6 (X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER BOUND TO PSYCHOSTIMULANT METHAMPHETAMINE)